# A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants

> **NCT06545253** · — · NOT_YET_RECRUITING · sponsor: **IRCCS Ospedale San Raffaele** · enrollment: 60 (estimated)

## Conditions studied

- USH2A Variant Retinitis Pigmentosa

## Interventions

- **DIAGNOSTIC_TEST:** microRNAs analysis

## Key facts

- **NCT ID:** NCT06545253
- **Lead sponsor:** IRCCS Ospedale San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08
- **Primary completion:** 2025-02
- **Final completion:** 2027-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06545253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06545253, "A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06545253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*